VEGFA and breast cancer: Srivastava et al. reported that MS-275 inhibited tumor cell proliferation, angiogenesis, metastasis and reversing EMT in vivo breast cancer xenograft model by causing “cadherin switch” and decreased expression of VEGF, HIF-1, MMP-2 and MMP-9 [42].